AC
CALA

Athanor Capital’s Calithera Biosciences, Inc CALA Stock Holding History

Athanor Capital’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,443
Closed -$169K – 848
2020
Q3 		$169K Sell
2,443
-1,033
-30% -$90.1K 0.01% 505
2020
Q2 		$367K Buy
+3,476
New +$413K 0.02% 367
2020
Q1 		– Sell
-2,395
Closed -$273K – 403
2019
Q4 		$273K Buy
+2,395
New +$180K 0.01% 322

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Athanor Capital's CALA Position: Q4 2020 in Review

Athanor Capital sold out of Calithera Biosciences, Inc (CALA) in Q4 2020, closing a stake of 2,443 shares — an estimated $169K sold.

Athanor Capital first reported a position in CALA in Q4 2019 and held it in 3 quarters. The position peaked at $367K in Q2 2020. 105 funds tracked by Wall St. Rank hold CALA as of Q4 2020.

  • Athanor Capital reported no remaining Calithera Biosciences, Inc position as of Q4 2020 after selling out during the quarter.
  • Athanor Capital sold 2,443 Calithera Biosciences, Inc shares in Q4 2020, an estimated $169K.
  • Athanor Capital first reported a position in Calithera Biosciences, Inc in Q4 2019 and held it in 3 quarters.
  • Athanor Capital's Calithera Biosciences, Inc position peaked at $367K in Q2 2020.
  • 105 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2020.

Based on Athanor Capital's 13F filing for Q4 2020, filed 16 Feb 2021.